Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Frontiers in Pharmacology|August 5, 2022
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European CountriesAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Frontiers in Pharmacology|March 3, 2020
Patient-Level Effectiveness Prediction Modeling for Glioblastoma Using Classification TreesTine Geldof, Nancy Van Damme, Isabelle Huys, et al.
Seminars in Cancer Biology|January 27, 2020
Repurposing drugs in oncology: From candidate selection to clinical adoptionPan Pantziarka, Ciska Verbaanderd, Isabelle Huys, et al.
Frontiers in Pharmacology|January 2, 2023
Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysisTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 24, 2012
"Trust is not something you can reclaim easily": patenting in the field of direct-to-consumer genetic testingSigrid Sterckx, Julian Cockbain, Heidi Howard, et al.
Frontiers in Medicine|January 27, 2023
An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and SpainTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.
Frontiers in Pharmacology|April 20, 2017
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the FutureKim Pauwels, Isabelle Huys, Sabine Vogler, et al.
Frontiers in Pharmacology|September 12, 2022
How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of CancerRobbe Saesen, Georgios Kantidakis, Ann Marinus, et al.
BMJ Open|January 9, 2025
Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020Zilke Claessens, Steffen Fieuws, Joël Daems, et al.
Frontiers in Medicine|March 3, 2020
Sharing of Clinical Trial Data and Samples: The Cancer Patient PerspectiveStefanie Broes, Ciska Verbaanderd, Minne Casteels, et al.
Pageof 22